SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-23-046470
Filing Date
2023-04-18
Accepted
2023-04-18 09:25:44
Documents
220
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F grfs-20221231x20f.htm   iXBRL 20-F 12950705
2 EXHIBIT 1.1 grfs-20221231xex1d1.htm EX-1.1 178443
3 EXHIBIT 2.7 grfs-20221231xex2d7.htm EX-2.7 31354
4 EXHIBIT 2.8 grfs-20221231xex2d8.htm EX-2.8 47532
5 EXHIBIT 2.11 grfs-20221231xex2d11.htm EX-2.11 40342
6 EXHIBIT 2.12 grfs-20221231xex2d12.htm EX-2.12 45706
7 EXHIBIT 2.14 grfs-20221231xex2d14.htm EX-2.14 73848
8 EXHIBIT 2.15 grfs-20221231xex2d15.htm EX-2.15 87929
9 EXHIBIT 4.3 grfs-20221231xex4d3.htm EX-4.3 32367
10 EXHIBIT 4.4 grfs-20221231xex4d4.htm EX-4.4 46028
11 EXHIBIT 4.5 grfs-20221231xex4d5.htm EX-4.5 88312
12 EXHIBIT 12.1 grfs-20221231xex12d1.htm EX-12.1 22440
13 EXHIBIT 12.2 grfs-20221231xex12d2.htm EX-12.2 12219
14 EXHIBIT 13.1 grfs-20221231xex13d1.htm EX-13.1 10106
20 GRAPHIC grfs-20221231x20f003.jpg GRAPHIC 77915
  Complete submission text file 0001104659-23-046470.txt   58568631

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION SCHEMA grfs-20221231.xsd EX-101.SCH 300580
16 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE grfs-20221231_cal.xml EX-101.CAL 196795
17 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE grfs-20221231_def.xml EX-101.DEF 944626
18 XBRL TAXONOMY EXTENSION LABEL LINKBASE grfs-20221231_lab.xml EX-101.LAB 1785508
19 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grfs-20221231_pre.xml EX-101.PRE 1490965
214 EXTRACTED XBRL INSTANCE DOCUMENT grfs-20221231x20f_htm.xml XML 17194877
Mailing Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036
Business Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036 212-969-3335
Grifols SA (Filer) CIK: 0001438569 (see all company filings)

IRS No.: 000000000
Type: 20-F | Act: 34 | File No.: 001-35193 | Film No.: 23825675
SIC: 2834 Pharmaceutical Preparations